TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14510796

Group type: EXPERIMENTAL
Intervention: Contact-topical anaesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Peribulbar injection anaesthesia
Number of subjects: 100
Study: 10761968

Group type: EXPERIMENTAL
Intervention: Education/feedback intervention program and patient awareness program
Number of subjects: 1575

Group type: EXPERIMENTAL
Intervention: Alcohol-based waterless hand antiseptic (1 dispenser for every 4 patients, then 1 for each patient)
Number of subjects: 1575
Study: 8970271

Group type: EXPERIMENTAL
Intervention: Dexamethasone iontophoresis (1 ml of DEX at 4 mg/ml mixed with 1 ml of sterile water)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dexamethasone iontophoresis
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (2 ml of saline solution)
Number of subjects: 10
Study: 1625127

Group type: EXPERIMENTAL
Intervention: Ornidazole
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Penicillin plus tobramycin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 100

Group type: COMPARATOR
Intervention: No prophylactic antibiotic
Number of subjects: 100
Study: 6367096

Group type: EXPERIMENTAL
Intervention: Quinidine
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 31262439

Group type: EXPERIMENTAL
Intervention: Various coping strategies for re-engaging in everyday life and physical activities
Number of subjects: 16
Study: 28980482

Group type: EXPERIMENTAL
Intervention: Nonoperative management for base fractures
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonoperative management for shaft fractures
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonoperative management for neck fractures
Number of subjects: 60
Study: 27713964

Group type: EXPERIMENTAL
Intervention: Inositol-enriched beverage (IEB) (2.0 g twice a day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sweetened beverage based on sucrose (SB)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Inositol-enriched beverage (IEB)
Number of subjects: 44
Study: 24567620

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 2061

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2061
Study: 22959954

Group type: EXPERIMENTAL
Intervention: Lowering dietary linoleic acid for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 20048099

Group type: EXPERIMENTAL
Intervention: Lateral column lengthening with lateral plantar pain
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lateral column lengthening without lateral plantar pain
Number of subjects: 10
Study: 18008121

Group type: EXPERIMENTAL
Intervention: 2.5 mg droperidol intravenously
Number of subjects: 52

Group type: COMPARATOR
Intervention: No droperidol
Number of subjects: 52
Study: 15625214

Group type: EXPERIMENTAL
Intervention: Exposure and ritual prevention
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Exposure and ritual prevention plus clomipramine
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 17459901

Group type: EXPERIMENTAL
Intervention: l‐NMMA 0.15 mg/kg
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: l‐NMMA 0.5 mg/kg
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: l‐NMMA 1.0 mg/kg
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: l‐NMMA 1.5 mg/kg
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 11196401

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials in Dental Research (RCT‐Ds)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical Trials in Dental Research
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized Controlled Trials in Medicine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analyses in Dental and Medical Research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dental Research Publications
Number of subjects: 0
Study: 8853216

Group type: EXPERIMENTAL
Intervention: Paroxetine (30 mg daily)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Nefazodone (400 mg daily)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 1535321

Group type: EXPERIMENTAL
Intervention: Inhaled ipratropium bromide (40 micrograms)
Number of subjects: 12
Study: 6090017

Group type: EXPERIMENTAL
Intervention: teniposide
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: amsacrine
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: zinostatin
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Weight loss, extensive disease, nonambulatory status
Number of subjects: 82
Study: 31328463

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg daily until progression or unacceptable toxicity
Number of subjects: 54
Study: 29140116

Group type: EXPERIMENTAL
Intervention: Descriptive and numeric graphical risk information for a 2-cm renal tumor
Number of subjects: 299

Group type: COMPARATOR
Intervention: Descriptive risk information only for a 2-cm renal tumor
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Numeric risk information for a 2-cm renal tumor
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: All risk information types
Number of subjects: 299
Study: 27798543

Group type: EXPERIMENTAL
Intervention: Supported Employment (SE) + Compensatory Cognitive Training (CCT)
Number of subjects: 40
Study: 25499342

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 1005
Study: 22541894

Group type: EXPERIMENTAL
Intervention: Twice-daily 75%/25% neutral protamine lispro/lispro mix
Number of subjects: 14

Group type: COMPARATOR
Intervention: Once daily insulin glargine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both insulin regimens
Number of subjects: 14
Study: 20598991

Group type: EXPERIMENTAL
Intervention: Change in lumen area
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Change in plaque area
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Height
Number of subjects: 207
Study: 18924019

Group type: EXPERIMENTAL
Intervention: Miniaturised cardiopulmonary bypass circuit (group M)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass circuit (group C)
Number of subjects: 60
Study: 15817864

Group type: EXPERIMENTAL
Intervention: 100 mg vitamin C/d
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 12219861

Group type: EXPERIMENTAL
Intervention: Positive mood state in extraverts
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Neutral or negative mood state in introverts
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Trait-consistent moods
Number of subjects: 4
Study: 9873216

Group type: EXPERIMENTAL
Intervention: Allopurinol, thiazide, potassium citrate, potassium‐magnesium citrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative program (high fluid intake and dietary modification)
Number of subjects: 0
Study: 8540507

Group type: EXPERIMENTAL
Intervention: ColoCARE Self‐Test pads
Number of subjects: 102

Group type: COMPARATOR
Intervention: Hemoccult II SENSA
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: ColoCARE
Number of subjects: 102
Study: 30947913

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with everolimus-eluting stents
Number of subjects: 1905

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1905
Study: 30076613

Group type: EXPERIMENTAL
Intervention: SRP + Probiotic (Bifidobacterium animalis subsp. lactis HN019), n=20
Number of subjects: 41

Group type: COMPARATOR
Intervention: SRP + Placebo, n=21
Number of subjects: 41
Study: 27072080

Group type: EXPERIMENTAL
Intervention: Alcohol management intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 25047649

Group type: EXPERIMENTAL
Intervention: Botnia clamp
Number of subjects: 22

Group type: COMPARATOR
Intervention: SHEC
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: IVGTT
Number of subjects: 22
Study: 22724562

Group type: EXPERIMENTAL
Intervention: Spiritually based intervention
Number of subjects: 316

Group type: COMPARATOR
Intervention: Nonspiritual comparison
Number of subjects: 316
Study: 19057523

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg q.d.
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Lorcaserin 15 mg q.d.
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg b.i.d.
Number of subjects: 469

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study: 17474540

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol 15 mg/kg
Number of subjects: 67

Group type: COMPARATOR
Intervention: Propacetamol 30 mg/kg
Number of subjects: 67
Study: 15151350

Group type: EXPERIMENTAL
Intervention: Personalized drinking feedback (PDF) delivered with a motivational interview (MI)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Personalized drinking feedback (PDF) without a motivational interview (MI)
Number of subjects: 54
Study: 11209008

Group type: EXPERIMENTAL
Intervention: 10 mg atorvastatin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.2 mg cerivastatin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 9842612

Group type: EXPERIMENTAL
Intervention: Jogging at 55% of age-adjusted maximum heart rate
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Jogging at 75% of age-adjusted maximum heart rate
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Jogging at 79% of age-adjusted maximum heart rate
Number of subjects: 91
Study: 8124988

Group type: EXPERIMENTAL
Intervention: Standard intravenous zinc therapy
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Supplemental intravenous zinc therapy
Number of subjects: 8
Study: 2535873

Group type: EXPERIMENTAL
Intervention: MMR vaccine with varicella vaccine
Number of subjects: 101

Group type: COMPARATOR
Intervention: MMR vaccine with placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Varicella vaccine
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 101
Study: 790553

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 128

Group type: COMPARATOR
Intervention: Ketoprofen 150 mg daily
Number of subjects: 128

Group type: COMPARATOR
Intervention: Indomethacin 100 mg daily
Number of subjects: 128
Study: 31079993

Group type: EXPERIMENTAL
Intervention: Sensor-guided TKA
Number of subjects: 318

Group type: COMPARATOR
Intervention: Surgeon-guided TKA
Number of subjects: 318
Study: 28501736

Group type: EXPERIMENTAL
Intervention: Mindfulness-based group therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25697420

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prasugrel 30 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Prasugrel 10 mg
Number of subjects: 20
Study: 22581848

Group type: EXPERIMENTAL
Intervention: 40 mg Methylphenidate (MPH)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 20836726

Group type: EXPERIMENTAL
Intervention: OC containing 35 μg ethinylestradiol plus 2 mg cyproterone acetate
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: OC containing 30 μg ethinylestradiol plus 3 mg drospirenone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Metformin 850 mg × 2
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: OC treatment (both groups A and B)
Number of subjects: 45
Study: 19228496

Group type: EXPERIMENTAL
Intervention: PolyHeme
Number of subjects: 714

Group type: COMPARATOR
Intervention: Control (crystalloid)
Number of subjects: 714
Study: 16680293

Group type: EXPERIMENTAL
Intervention: Echo off‐line applicative (software for obtaining digitized image measurements)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional method (comparison group)
Number of subjects: 56
Study: 12691695

Group type: EXPERIMENTAL
Intervention: Health Services Research (HSR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Institutional Quality Improvement (QI) initiatives
Number of subjects: 0
Study: 10735697

Group type: EXPERIMENTAL
Intervention: Modified reperfusion (normothermic reperfusate enhanced with glutamate and aspartate for 5 minutes before removal of the cross-clamp)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (unmodified reperfusion)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 8757208

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily for 6 weeks
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 1374266

Group type: EXPERIMENTAL
Intervention: Aprotinin (560 mg; n = 10)
Number of subjects: 20
Study: 3880735

Group type: EXPERIMENTAL
Intervention: Mesterolone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study: 29360672

Group type: EXPERIMENTAL
Intervention: Psychoeducational Intervention (PEI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional pamphlet education (Control)
Number of subjects: 40
Study: 27429724

Group type: EXPERIMENTAL
Intervention: Triamcinolone ointment and zinc-containing mouthwash
Number of subjects: 20

Group type: COMPARATOR
Intervention: Triamcinolone ointment alone
Number of subjects: 20
Study: 25588397

Group type: EXPERIMENTAL
Intervention: New method of conduction anesthesia by blocking the infraorbital nerve along its entire length
Number of subjects: 0
Study: 22795360

Group type: EXPERIMENTAL
Intervention: LLPR system (interactive video game-based rehabilitation) for lower limb muscle power training, 30-min training, twice a week for 6 weeks (12 sessions)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group performing slow speed STS movements and strengthening and balance exercises, same frequency and duration as exercise group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: LLPR system (exercise group)
Number of subjects: 40
Study: 20155790

Group type: EXPERIMENTAL
Intervention: Meta-analysis of small RCTs
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Surgical RCTs
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Meta-analysis of small trials
Number of subjects: 87
Study: 18312806

Group type: EXPERIMENTAL
Intervention: Five discussion group sessions focusing on healthful eating, physical activity, goal-setting, and social support.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 200
Study: 16360432

Group type: EXPERIMENTAL
Intervention: 120 shock waves per minute
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: 90 shock waves per minute
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: 60 shock waves per minute
Number of subjects: 170
Study: 11956124

Group type: EXPERIMENTAL
Intervention: Folic acid at 5 mg/m2
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 9604997

Group type: EXPERIMENTAL
Intervention: CYFRA 21-1 tumor marker
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (77 patients without evidence of neoplasm)
Number of subjects: 80
Study: 7697954

Group type: EXPERIMENTAL
Intervention: 2 mg immediate-release alprazolam
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 2 mg extended-release alprazolam
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 3 mg extended-release alprazolam
Number of subjects: 14

Group type: COMPARATOR
Intervention: Immediate-release alprazolam (both doses)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Extended-release alprazolam (both doses)
Number of subjects: 14
Study: 2497634

Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 21

Group type: COMPARATOR
Intervention: High-amylose cornstarch
Number of subjects: 21
Study: 385023

Group type: EXPERIMENTAL
Intervention: Labetalol (600 mg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination treatment (Labetalol and Bendrofluazide)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 10
Study: 31703567

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 38
Study: 29040119

Group type: EXPERIMENTAL
Intervention: Biomaterial-free cultured oral mucosal epithelial cell sheets (COMECs)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Penetrating keratoplasty after stabilization of COMEC transplant
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: COMECs transplantation
Number of subjects: 8
Study: 26932802

Group type: COMPARATOR
Intervention: Pomalidomide 4 mg on days 1 to 21 of a 28‐day cycle with weekly dexamethasone (arm B)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pomalidomide, dexamethasone, and cyclophosphamide (PomCyDex) 400 mg orally on days 1, 8, and 15 (arm C)
Number of subjects: 70
Study: 25709419

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training with virtual spatial navigation task (CCT) during bed rest
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no cognitive training)
Number of subjects: 16
Study: 23134528

Group type: EXPERIMENTAL
Intervention: Letrozole/antagonist protocol (mild stimulation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: GnRH agonist protocol (microdose flare)
Number of subjects: 60
Study: 19756811

Group type: EXPERIMENTAL
Intervention: Increased social support through volunteer visitors for dementia patients
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 84
Study: 18467673

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.6 mg/kg)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Prednisone (2 mg/kg)
Number of subjects: 89
Study: 16814257

Group type: EXPERIMENTAL
Intervention: Ethyl-eicosapentanoate (EPA) 6 g/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14651548

Group type: EXPERIMENTAL
Intervention: Tongue brushing with a hard toothbrush wetted with 0.12% chlorhexidine gluconate
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no tongue cleaning)
Number of subjects: 28
Study: 11517825

Group type: EXPERIMENTAL
Intervention: Low-sodium diet (50 mmol Na/day)
Number of subjects: 13

Group type: COMPARATOR
Intervention: High-sodium diet (250 mmol Na/day)
Number of subjects: 13
Study: 8959788

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms four times daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 40
Study: 1493985

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 250 mg twice daily for three days
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 4019951

Group type: EXPERIMENTAL
Intervention: PRW A greater than 500,000
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: PRW B 200,000 to 20,000,000
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: PRW C greater than 20,000,000
Number of subjects: 21
Study: 31981294

Group type: EXPERIMENTAL
Intervention: Action Observation Treatment (AOT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Videogame Observation Treatment (VOT)
Number of subjects: 8
Study: 29174128

Group type: EXPERIMENTAL
Intervention: IUI with ovarian stimulation (oral clomifene citrate 50-150 mg or oral letrozole 2.5-7.5 mg, days 2-6)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Expectant management (advised to be sexually active around ovulation)
Number of subjects: 201
Study: 27000324

Group type: EXPERIMENTAL
Intervention: Structured physical activity (walking 150 min/week, strength, flexibility, and balance training)
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Health education (workshops and upper extremity stretching exercises)
Number of subjects: 1635
Study: 25495953

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg/d) for 8 weeks
Number of subjects: 34
Study: 23128104

Group type: EXPERIMENTAL
Intervention: Fish oil (1-g capsules containing ≥840 mg n-3-PUFAs as ethyl esters) with preoperative loading of 10 g over 3 to 5 days followed by 2 g/d until hospital discharge or postoperative day 10.
Number of subjects: 1516

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1516

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 1516
Study: 20975369

Group type: EXPERIMENTAL
Intervention: 5-RM DP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-RM AP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10-RM DP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10-RM AP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-RM loads
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10-RM loads
Number of subjects: 0
Study: 18539225

Group type: EXPERIMENTAL
Intervention: Home-care intervention
Number of subjects: 36059

Group type: EXPERIMENTAL
Intervention: Community-care intervention
Number of subjects: 36059

Group type: COMPARATOR
Intervention: Comparison arm
Number of subjects: 36059
Study: 16858958

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine 600 mg/d
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine 1200 mg/d
Number of subjects: 39
Study: 12456910

Group type: EXPERIMENTAL
Intervention: Pimecrolimus (Elidel, SDZ ASM 981) cream 1%
Number of subjects: 403

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Pimecrolimus (Elidel, SDZ ASM 981) cream 1% (after all patients switched at week 6)
Number of subjects: 403
Study: 10878516

Group type: EXPERIMENTAL
Intervention: Oral ofloxacin (400 mg every 12 hours)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intravenous imipenem-cilastatin (500 mg every 6 hours)
Number of subjects: 32
Study: 7727089

Group type: EXPERIMENTAL
Intervention: Unilateral functional endoscopic sinus surgery (FESS) in piglets
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Histologic examination of sinus bone in children
Number of subjects: 84
Study: 2447198

Group type: EXPERIMENTAL
Intervention: Rhinovirus strains
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0